Cladis Investment Advisory, LLC - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cladis Investment Advisory, LLC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q1 2023$32,320
+49623.1%
80,000
-46.7%
0.03%
-54.1%
Q4 2022$65
-100.0%
150,000
-72.8%
0.07%
-62.8%
Q3 2022$155,000
-41.5%
552,000
-25.1%
0.20%
-36.0%
Q2 2022$265,000
-64.9%
737,000
-34.5%
0.31%
-56.9%
Q1 2022$754,000
-47.1%
1,126,000
+2.0%
0.72%
-45.1%
Q4 2021$1,424,0001,104,0001.31%
Other shareholders
SIO GENE THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,969,987$8,108,0000.98%
Opaleye Management Inc. 2,000,000$5,258,0000.87%
Rubric Capital Management LP 3,000,000$8,190,0000.52%
Prosight Management, LP 256,115$699,0000.44%
ACT CAPITAL MANAGEMENT, LLC 185,000$506,0000.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,489,000$14,985,0000.22%
GSA CAPITAL PARTNERS LLP 363,887$993,0000.11%
KNOTT DAVID M 80,000$218,0000.08%
Hudson Bay Capital Management LP 1,540,000$4,204,0000.05%
APOGEM CAPITAL LLC 19,401$53,0000.03%
View complete list of SIO GENE THERAPIES INC shareholders